These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8724819)

  • 1. The role of lipids in cardiovascular disease: lessons from rare mutations and special populations.
    Hegele RA
    Clin Invest Med; 1996 Jun; 19(3):161-70. PubMed ID: 8724819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The genetic bases of the lipid metabolic disorders in atherosclerosis].
    Tselĭko VI
    Tsitol Genet; 1996; 30(2):74-82. PubMed ID: 9281205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genes, small effects, and the prediction of atherosclerosis.
    Hegele RA
    Crit Rev Clin Lab Sci; 1997; 34(4):343-67. PubMed ID: 9288444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of plasma lipoproteins.
    Pollex RL; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):600-9. PubMed ID: 17957207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetics and dyslipidemias].
    Brousseau T; Fruchart JCh
    Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1116-20. PubMed ID: 14694789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidaemia and coronary heart disease: nature vs nurture.
    Hegele RA
    Br J Hosp Med; 1995 Aug 16-Sep 5; 54(4):143-6. PubMed ID: 7582364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related disparities: influence of environmental factors.
    Olden K; White SL
    Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminopathies and atherosclerosis.
    Al-Shali KZ; Hegele RA
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipidemia, atherosclerosis and heart disease. Epidemiology and prevention].
    Rabaneda Vallecillos R
    Rev Enferm; 1990 Dec; 13(148):68-73. PubMed ID: 2277915
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.
    Gong G; Whittemore AS
    Genet Epidemiol; 2003 Apr; 24(3):173-80. PubMed ID: 12652521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoproteins and cardiovascular risk--from genetics to CHD prevention.
    Cullen P; Funke H; Schulte H; Assmann G
    Eur Heart J; 1998 Apr; 19 Suppl C():C5-11. PubMed ID: 9597420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigree.
    Richards JE; Ritch R; Lichter PR; Rozsa FW; Stringham HM; Caronia RM; Johnson D; Abundo GP; Willcockson J; Downs CA; Thompson DA; Musarella MA; Gupta N; Othman MI; Torrez DM; Herman SB; Wong DJ; Higashi M; Boehnke M
    Ophthalmology; 1998 Sep; 105(9):1698-707. PubMed ID: 9754180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.